The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Articles|May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
Author(s)Sydney Jennings
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, May 16, 2022, at 2:15 PM, EDT:
46.4% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
• 66.4% of total US population
• 70.6% of US population aged ≥5 years
• 74.9% of US population aged ≥12 years
• 76.4% of US population aged ≥18 years
• 90.7% of US population aged ≥65 years
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, May 16, 2022 at 4:20 PM, EDT, there have been:
• 82 600 106 confirmed cases and
• 999 800 deaths
• 999 800 deaths
In the past 28 days, the 3 states with the most new cases are:
1. New York: 229 366
2. California: 187 269
3. Illinois: 125 519
2. California: 187 269
3. Illinois: 125 519
Deaths: California has the highest number of deaths due to COVID-19 with 90 623 reported fatalities, followed by Texas with 88 226 and Florida with 74 133.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 521 864 627 confirmed cases, 6 266 459 deaths, and 11 418 549 469 vaccine doses administered.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement